163 related articles for article (PubMed ID: 30980513)
21. Long non-coding RNA AFAP1-AS1 promotes proliferation and invasion in prostate cancer via targeting miR-512-3p.
Wang K; Sun H; Sun T; Qu H; Xie Q; Lv H; Hu B
Gene; 2020 Feb; 726():144169. PubMed ID: 31669642
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway.
Liu H; Han L; Liu Z; Gao N
J Cell Physiol; 2019 Aug; 234(8):13843-13850. PubMed ID: 30618167
[TBL] [Abstract][Full Text] [Related]
23.
Zheng Y; Su L; Tan J; Dong F
Bioengineered; 2022 Mar; 13(3):4911-4922. PubMed ID: 35152841
[TBL] [Abstract][Full Text] [Related]
24. Prognostic potential of MNX1-AS1 in chemotherapy of colorectal carcinoma.
Zhong G; Zhou M; Wang Z; Zhu W
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):243-247. PubMed ID: 38279423
[TBL] [Abstract][Full Text] [Related]
25. LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.
Li F; Chen Q; Xue H; Zhang L; Wang K; Shen F
Cell Death Dis; 2020 Oct; 11(10):894. PubMed ID: 33093444
[TBL] [Abstract][Full Text] [Related]
26. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway.
Liu X; Yang Q; Yan J; Zhang X; Zheng M
J Cell Biochem; 2019 Mar; 120(3):4268-4277. PubMed ID: 30302806
[TBL] [Abstract][Full Text] [Related]
27. LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma.
Zhao Y; Wang N; Zhang X; Liu H; Yang S
J Cell Mol Med; 2019 Dec; 23(12):8206-8218. PubMed ID: 31638344
[TBL] [Abstract][Full Text] [Related]
28. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
Liu Z; Wang N; Wang F; Zhang S; Ding J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1.
Zhang YX; Cui HX; Liu L; Yi GK
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6045-6052. PubMed ID: 31364121
[TBL] [Abstract][Full Text] [Related]
32. LncRNA UBE2R2-AS1, as prognostic marker, promotes cell proliferation and EMT in prostate cancer.
Wang F; Zhao M; Jiang Y; Xia S; Sun D; Zhou D; Dong Z
Histol Histopathol; 2023 Jun; 38(6):637-645. PubMed ID: 35916204
[TBL] [Abstract][Full Text] [Related]
33. LncRNA SSTR5-AS1 as a Prognostic Marker Promotes Cell Proliferation and Epithelial-to-Mesenchymal Transition in Prostate Cancer.
Yuan S; Bi J; Zhang Y
Crit Rev Eukaryot Gene Expr; 2023; 33(2):1-12. PubMed ID: 36734853
[TBL] [Abstract][Full Text] [Related]
34. Pan-Cancer Analysis Identifies
Ragusa D; Tosi S; Sisu C
Cells; 2022 Nov; 11(22):. PubMed ID: 36429006
[TBL] [Abstract][Full Text] [Related]
35. Effect of lncRNA BNC2-AS1 on the Proliferation, Migration and Invasion of Gastric Cancer Cells.
Liu C; Yang G; Liu N; Zhou Z; Cao B; Zhou P; Yang B
Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549996
[No Abstract] [Full Text] [Related]
36. Long noncoding RNA AFAP1-AS1 accelerates the proliferation and metastasis of prostate cancer via inhibiting RBM5 expression.
Yang ZT; An F; Hu JD; Zhao WH
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3284-3290. PubMed ID: 31081081
[TBL] [Abstract][Full Text] [Related]
37. MNX1-AS1 accelerates the epithelial-mesenchymal transition in osteosarcoma cells by activating MNX1 as a functional oncogene.
Wu F; Zhong Y; Lang XB; Tu YL; Sun SF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8194-8202. PubMed ID: 31646549
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
39. MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer.
Cheng Y; Pan Y; Pan Y; Wang O
Cancer Manag Res; 2019; 11():803-812. PubMed ID: 30697072
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
